Sinopharm Group (SHTDF) News Today $2.70 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsShort InterestStock AnalysisChartFinancialsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period April 29, 2024 | marketwatch.comSinopharm Group Shares Fall as Higher Costs Cut Into Quarterly ProfitApril 6, 2024 | morningstar.comSinopharm Group Co Ltd ADR X2S1February 21, 2024 | morningstar.comSinopharm Group Co Ltd 01099January 30, 2024 | morningstar.comSinopharm Group Co Ltd X2SNovember 8, 2023 | morningstar.comSinopharm Group Co Ltd SHTDFMay 12, 2023 | msn.comSinopharm Group (HKEX:1099) Price Target Increased by 8.31% to 29.48April 13, 2023 | finance.yahoo.comPfizer signs strategic cooperation pact with China's SinopharmApril 6, 2023 | msn.comWHO chief expects COVID emergency to end this yearMarch 24, 2023 | msn.comChina approves its first mRNA Covid-19 vaccineMarch 22, 2023 | news.yahoo.comChina approves first home-grown mRNA Covid vaccineFebruary 23, 2023 | forbes.comSinopharm GroupJanuary 20, 2023 | news.yahoo.comSinopharm unit gets OK for clinical trials of mRNA COVID vaccineJanuary 20, 2023 | msn.comPharma major Sinopharm gets approval for clinical trials of mRNA Covid-19 vaccineDecember 8, 2022 | reuters.comSinopharm's second Chinese herb shot is potentDecember 2, 2022 | seekingalpha.comVaxxinity says COVID vaccine outperformed Astra and Sinopharm shots as boosterSeptember 28, 2022 | seekingalpha.comMerck in pact with Sinopharm to launch oral COVID-19 therapy in ChinaSeptember 15, 2022 | msn.comSinopharm to boost local COVID vaccine production in AfricaSeptember 7, 2022 | msn.comChina’s Sinovac to test Omicron-targeting vaccines in ChileJuly 27, 2022 | msn.comDaesang to set up joint venture with China Sinopharm InternationalJuly 17, 2022 | seekingalpha.comWeek In Review: Qiming Closes $3.2 Billion For China Healthcare And Technology InvestmentsJuly 4, 2022 | msn.comHong Kong could have 3 Omicron-targeting jabs by end of year, as health expert reveals Sinopharm hopes to make new vaccine available by DecemberJune 27, 2022 | msn.comChina Donates 10 Mil Doses of Sinopharm COVID-19 Vaccines, SyringesJune 22, 2022 | usnews.comSome Omicron Sub-Variants Escaping Antibodies From Sinopharm Shot -Chinese StudyJune 21, 2022 | reuters.comSome Omicron sub-variants escaping antibodies from Sinopharm shot - Chinese studyMay 31, 2022 | msn.comUniversity of Hong Kong, Sinopharm launch city’s first trial for Omicron-targeting vaccine which could be ready in NovemberMay 28, 2022 | seekingalpha.comCanSino's Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?April 18, 2022 | seekingalpha.comSinovac Biotech's Omicron-specific vaccine cleared for clinical trial in Hong KongApril 16, 2022 | msn.comSinopharm, Sinovac vaccine candidates for Omicron variant gets clearance for clinical trialApril 3, 2022 | bloomberg.comSinopharm Says Second-Generation Vaccine Approved for TrialFebruary 22, 2022 | reuters.comAntibody triggered by Sinopharm COVID booster wanes after six months - studyFebruary 9, 2022 | msn.comAbu Dhabi makes fourth doses of Pfizer and Sinopharm Covid-19 vaccines availableFebruary 8, 2022 | msn.comAll required data received for Sinopharm vaccine to be registered - SahpraFebruary 7, 2022 | msn.comSahpra registers Sinopharm, Pfizer COVID-19 vaccines for use in SAJanuary 14, 2022 | nasdaq.comSinopharm Group Co Ltd (SHTDF)January 7, 2022 | msn.comDuterte receives Sinopharm COVID-19 boosterJanuary 5, 2022 | msn.comWHO: shots such as Sinopharm and Sinovac prevent 'severe hospitalisation' from OmicronOctober 15, 2021 | msn.comSinopharm Covid-19 vaccine now available in MalaysiaOctober 15, 2021 | msn.comSinopharm vaccine now available at GPs, private hospitalsOctober 12, 2021 | msn.comWHO group backs third Covid-19 shot for elderly vaccinated with Sinovac or SinopharmSeptember 29, 2021 | businesswire.comChromaDex Partners with Sinopharm Xingsha for Cross-Border Sales of Tru Niagen® into Mainland ChinaSeptember 9, 2021 | msn.comChina’s Sinopharm Group contemplates vaccine plant in SLSeptember 8, 2021 | msn.comDuopharma denies appointing Bintai Healthcare, other parties as distributor of Sinopharm's Covid-19 vaccineAugust 29, 2021 | wsj.comSinopharm Covid Vaccine Seen as Less Effective in Bahrain StudyAugust 29, 2021 | msn.comCuba to deploy China's Sinopharm alongside homegrown vaccinesAugust 25, 2021 | msn.comCoronavirus: Sinopharm’s twin approach to variants aims for improved vaccine while testing booster shotAugust 24, 2021 | msn.comSinopharm executive suggests vaccinated people accept booster shots after China builds herd immunity - Global TimesAugust 23, 2021 | msn.comSinopharm vaccine gets EUA from FDAAugust 21, 2021 | msn.comDuterte thanks China for giving 1M doses of Sinopharm vaccineAugust 18, 2021 | msn.comGLOBALink | Bangladesh signs agreement to manufacture China's Sinopharm COVID-19 inactivated vaccineAugust 18, 2021 | msn.comAbu Dhabi makes Pfizer, Sinopharm booster shots available Get Sinopharm Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SHTDF and its competitors with MarketBeat's FREE daily newsletter. Email Address “Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event. You can find out what they are by clicking here now. SHTDF Media Mentions By Week SHTDF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SHTDF News Sentiment▼0.000.62▲Average Medical News Sentiment SHTDF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SHTDF Articles This Week▼00▲SHTDF Articles Average Week Get Sinopharm Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SHTDF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: KOSK News Today SHTDY News Today TGIFF News Today FFNTF News Today ABSCF News Today ACONW News Today ACRHF News Today ACRDF News Today ADMT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SHTDF) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinopharm Group Co. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sinopharm Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.